Tuberculosis Research Advancement Centers (TRACs) (P30 Clinical Trial Not Allowed)
NIH will fund Tuberculosis Research Advancement Centers that build the next generation of TB researchers and provide shared expertise and resources for multidisciplinary basic and clinical TB research, with no clinical trials allowed.
⚑ P30 center mechanism · Clinical Trial Not Allowed · Foreign organizations, non-domestic components, and foreign components are not allowed
Unit fits — one characterization, each unit's own rules
| IPPRA | 58 good | portfolio topic: public_health; social/behavioral work is minor; funds basic research |
| Physical Sciences & Engineering (demo) | 55 good | technical depth: minor; funds basic research |
| Tom Love Innovation Hub | 15 none | deep-tech content; no commercialization signal |
Description
The purpose of this notice of funding opportunity (NOFO) is to support applications for the Tuberculosis (TB) Research Advancement Centers (TRACs) program. The goal of the TRACs is to develop the next generation of TB researchers and to catalyze multidisciplinary and innovative TB science by providing expertise and resources to facilitate basic and clinical TB research.
Eligibility
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations: Non-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement are not allowed.
Apply
View on Grants.gov → CONTACT: National Institutes of Health <NIAIDTRACS@mail.nih.gov>
Proposal brief
Proposal shell · National Institutes of Health conventions
Legacy IPPRA LLM assessment (v2.0, for comparison)
18/100 · gpt-5.4-mini · 2026-07-06
This is a tuberculosis research center program focused on basic and clinical TB science and researcher development, which is primarily biomedical rather than social/behavioral or policy research. IPPRA could only be a peripheral partner at best if there were a specific health communication or behavioral component, but that is not named in the NOFO. Public U.S. universities appear eligible, but the fit remains weak for IPPRA’s core portfolio.
Legacy scoring history
| 2026-07-06 | 18 | gpt-5.4-mini | This is a tuberculosis research center program focused on basic and clinical TB science and researcher development, which is primarily biomedical rather than social/behavioral or policy research. IPPRA could only be a peripheral partner at best if there were a specific health communication or behavioral component, but that is not named in the NOFO. Public U.S. universities appear eligible, but the fit remains weak for IPPRA’s core portfolio. |
| 2026-07-06 | 18 | gpt-5.4-mini | This is a tuberculosis research center mechanism focused on basic and clinical TB science, which is primarily biomedical rather than in IPPRA’s core social/behavioral and policy domains. IPPRA could contribute only indirectly through health communication, behavioral adherence, or implementation-related work, but those elements are not explicit in the NOFO. Public U.S. universities appear eligible, but the fit remains weak because the solicitation is not centered on community, policy, or communication research. |